Net Loss Per Share (Details) - Schedule of dilutive shares - shares	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021
Anti-dilutive shares	399,003,629	81,477,436
Convertible debt [Member]
Anti-dilutive shares	197,095,902	13,626,666
Stock options [Member]
Anti-dilutive shares	46,316,666	30,516,666
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	155,591,061	37,304,104

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration